Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer

Stopped The trial was closed due to the changing efficacy of treatments for metastatic urothelial cancer.

Conditions

• Metastatic Urothelial Carcinoma

Interventions

• OTHER: Laboratory Biomarker Analysis
• DRUG: Pemetrexed Disodium

Sponsor

M.D. Anderson Cancer Center

Collaborators

• [object Object]